These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 30915197)

  • 21. Identification of potential therapeutic compounds for Parkinson's disease using Drosophila and human cell models.
    Sanz FJ; Solana-Manrique C; Muñoz-Soriano V; Calap-Quintana P; Moltó MD; Paricio N
    Free Radic Biol Med; 2017 Jul; 108():683-691. PubMed ID: 28455141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives.
    Sarkar S; Raymick J; Imam S
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations between B Vitamins and Parkinson's Disease.
    Shen L
    Nutrients; 2015 Aug; 7(9):7197-208. PubMed ID: 26343714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. White matter microstructure damage in tremor-dominant Parkinson's disease patients.
    Luo C; Song W; Chen Q; Yang J; Gong Q; Shang HF
    Neuroradiology; 2017 Jul; 59(7):691-698. PubMed ID: 28540401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum vitamins and heavy metals in blood and urine, and the correlations among them in Parkinson's disease patients in China.
    Fukushima T; Tan X; Luo Y; Kanda H
    Neuroepidemiology; 2011; 36(4):240-4. PubMed ID: 21677448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurodegenerative signaling factors and mechanisms in Parkinson's pathology.
    Goswami P; Joshi N; Singh S
    Toxicol In Vitro; 2017 Sep; 43():104-112. PubMed ID: 28627426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, controlled pilot study of the effects of vitamin D supplementation on balance in Parkinson's disease: Does age matter?
    Hiller AL; Murchison CF; Lobb BM; O'Connor S; O'Connor M; Quinn JF
    PLoS One; 2018; 13(9):e0203637. PubMed ID: 30256811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New insight into the therapeutic role of the serotonergic system in Parkinson's disease.
    Ohno Y; Shimizu S; Tokudome K; Kunisawa N; Sasa M
    Prog Neurobiol; 2015 Nov; 134():104-21. PubMed ID: 26455457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Advance in studies on pathological mechanism of Parkinson's disease and traditional Chinese medicine experiments in prevention and treatment of Parkinson's disease].
    Xiong P; Chen X; Zhang N
    Zhongguo Zhong Yao Za Zhi; 2012 Mar; 37(5):686-91. PubMed ID: 22693916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between essential tremor and Parkinson's disease.
    Thenganatt MA; Jankovic J
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S162-5. PubMed ID: 26522219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of nutritional supplements in Parkinson's disease patients.
    Wolfrath SC; Borenstein AR; Schwartz S; Hauser RA; Sullivan KL; Zesiewicz TA
    Mov Disord; 2006 Aug; 21(8):1098-101. PubMed ID: 16639735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic anti-Parkinsonism activity of high doses of B vitamins in a chronic cellular model.
    Jia H; Liu Z; Li X; Feng Z; Hao J; Li X; Shen W; Zhang H; Liu J
    Neurobiol Aging; 2010 Apr; 31(4):636-46. PubMed ID: 18639366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The contributions of antioxidant activity of lipoic acid in reducing neurogenerative progression of Parkinson's disease: a review.
    De Araújo DP; Lobato Rde F; Cavalcanti JR; Sampaio LR; Araújo PV; Silva MC; Neves KR; Fonteles MM; Sousa FC; Vasconcelos SM
    Int J Neurosci; 2011 Feb; 121(2):51-7. PubMed ID: 21126109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary lipids and antioxidants in Parkinson's disease: a population-based, case-control study.
    Logroscino G; Marder K; Cote L; Tang MX; Shea S; Mayeux R
    Ann Neurol; 1996 Jan; 39(1):89-94. PubMed ID: 8572672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonergic mechanisms in Parkinson's disease: opposing results from preclinical and clinical data.
    Scholtissen B; Verhey FR; Steinbusch HW; Leentjens AF
    J Neural Transm (Vienna); 2006 Jan; 113(1):59-73. PubMed ID: 16252066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presynaptic dysfunction in Parkinson's disease: a focus on LRRK2.
    Belluzzi E; Greggio E; Piccoli G
    Biochem Soc Trans; 2012 Oct; 40(5):1111-6. PubMed ID: 22988874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antioxidant supplementation for lung disease in cystic fibrosis.
    Ciofu O; Lykkesfeldt J
    Cochrane Database Syst Rev; 2014 Aug; (8):CD007020. PubMed ID: 25102015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IDH2 deficiency promotes mitochondrial dysfunction and dopaminergic neurotoxicity: implications for Parkinson's disease.
    Kim H; Kim SH; Cha H; Kim SR; Lee JH; Park JW
    Free Radic Res; 2016 Aug; 50(8):853-60. PubMed ID: 27142242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria?
    Bogaerts V; Theuns J; van Broeckhoven C
    Genes Brain Behav; 2008 Mar; 7(2):129-51. PubMed ID: 17680806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.